Skip to main content
Top
Published in: Journal of General Internal Medicine 8/2007

01-08-2007 | Original Arti cle

Appointment-Keeping Behavior is Not Related to Medication Adherence in Hypertensive African Americans

Authors: Gbenga Ogedegbe, MD, MPH, MS, Antoinette Schoenthaler, MA, Senaida Fernandez, PhD

Published in: Journal of General Internal Medicine | Issue 8/2007

Login to get access

Abstract

OBJECTIVE

The relationship between appointment-keeping behavior, medication adherence (ADH), and systolic and diastolic blood pressure (SBP and DBP) was assessed in 153 hypertensive African Americans followed in a community-based practice.

METHODS

ADH was assessed with a self-report questionnaire. BP was obtained from electronic medical records and appointment attendance was determined from the log of all appointments made during the 12-month study period. Nonadherence rates were compared across appointment attendance categories with chi-square. Logistic regression was used to assess the relationship between ADH and appointment attendance, whereas multivariate analysis of covariance (MANCOVA) was used to examine the relationship between appointment attendance and BP.

RESULTS

Twenty-five percent of patients (87% women, mean age 52 years) did not miss any appointments, 44% missed 1–30%, and 31% missed greater than 30%. Adjusted nonadherence rates were similar for all 3 categories (70%, 66%, and 65%, respectively, p = 0.88) as were adjusted mean SBP and DBP in the MANCOVA model, [F (4, 218) = 1.13, p = .34]. Logistic regression analysis did not indicate a significant relationship between appointment attendance and ADH.

CONCLUSIONS

Appointment-keeping behavior was not related to ADH or BP among hypertensive African Americans. It should not be used as a proxy for ADH in this patient population.
Literature
1.
go back to reference Farley J, Hines S, Musk A, Ferrus S, Tepper V. Assessment of adherence to antiviral therapy in HIV-infected children using the medication event monitoring system, pharmacy refill, provider assessment, caregiver self-report, and appoinment keeping. J Acquir Immune Defic Syndr. 2003;33:211–8PubMedCrossRef Farley J, Hines S, Musk A, Ferrus S, Tepper V. Assessment of adherence to antiviral therapy in HIV-infected children using the medication event monitoring system, pharmacy refill, provider assessment, caregiver self-report, and appoinment keeping. J Acquir Immune Defic Syndr. 2003;33:211–8PubMedCrossRef
2.
go back to reference Karter AJ, Parker M, Moffet H, et al. Missed appointments and poor glycemic control: an opportunity to identify high-risk diabetic patients. Med Care. 2004;42(2):110–5PubMedCrossRef Karter AJ, Parker M, Moffet H, et al. Missed appointments and poor glycemic control: an opportunity to identify high-risk diabetic patients. Med Care. 2004;42(2):110–5PubMedCrossRef
3.
go back to reference Macharia WM, Leon G, Rowe BH, Stephenson BJ, Haynes RB. An overview of interventions to improve compliance with appointment keeping for medical services. JAMA 1992;267(13):1813–7PubMedCrossRef Macharia WM, Leon G, Rowe BH, Stephenson BJ, Haynes RB. An overview of interventions to improve compliance with appointment keeping for medical services. JAMA 1992;267(13):1813–7PubMedCrossRef
4.
go back to reference Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42(6):1206–52PubMedCrossRef Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42(6):1206–52PubMedCrossRef
5.
go back to reference Bell RL, Curb JD, Friedman LM, McIntyre KM, Payton-Ross C. Enhancement of visit adherence in the national beta-blocker heart attack trial. Control Clin Trials. 1985;6(2):89–101PubMedCrossRef Bell RL, Curb JD, Friedman LM, McIntyre KM, Payton-Ross C. Enhancement of visit adherence in the national beta-blocker heart attack trial. Control Clin Trials. 1985;6(2):89–101PubMedCrossRef
6.
go back to reference Connett JE, Stamler J. Responses of black and white males to the special intervention program of the Multiple Risk Factor Intervention Trial. Am Heart J. 1984;108(3 Pt 2):839-48PubMedCrossRef Connett JE, Stamler J. Responses of black and white males to the special intervention program of the Multiple Risk Factor Intervention Trial. Am Heart J. 1984;108(3 Pt 2):839-48PubMedCrossRef
7.
go back to reference Lee JY, Greene PG, Douglas M, et al. Appointment attendance, pill counts, and achievement of goal blood pressure in the African American Study of Kidney Disease and Hypertension Pilot Study. Control Clin Trials. 1996;17(4 Suppl):34S–39SPubMedCrossRef Lee JY, Greene PG, Douglas M, et al. Appointment attendance, pill counts, and achievement of goal blood pressure in the African American Study of Kidney Disease and Hypertension Pilot Study. Control Clin Trials. 1996;17(4 Suppl):34S–39SPubMedCrossRef
8.
go back to reference Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation 1997;95(4):1085–90PubMed Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation 1997;95(4):1085–90PubMed
9.
go back to reference Smith EO, Curb JD, Hardy RJ, Hawkins CM, Tyroler HA. Clinic attendance in the hypertension detection and follow-up program. Hypertension 1982;4(5):710–5PubMed Smith EO, Curb JD, Hardy RJ, Hawkins CM, Tyroler HA. Clinic attendance in the hypertension detection and follow-up program. Hypertension 1982;4(5):710–5PubMed
10.
go back to reference Webb PA. Effectiveness of patient education and psychosocial counseling in promoting compliance and control among hypertensive patients. J Fam Pract. 1980;10(6):1047–55PubMed Webb PA. Effectiveness of patient education and psychosocial counseling in promoting compliance and control among hypertensive patients. J Fam Pract. 1980;10(6):1047–55PubMed
11.
go back to reference Gerin W, Ogedegbe G, Schwartz JE, et al. Assessment of the white-coat effect. J Hypertens 2006;24(1):67–74PubMedCrossRef Gerin W, Ogedegbe G, Schwartz JE, et al. Assessment of the white-coat effect. J Hypertens 2006;24(1):67–74PubMedCrossRef
12.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83PubMedCrossRef
13.
go back to reference Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74PubMedCrossRef Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74PubMedCrossRef
14.
go back to reference Shea S, Misra D, Ehrlich M, Field L, Francis C. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health. 1992;82(12):1607–12PubMedCrossRef Shea S, Misra D, Ehrlich M, Field L, Francis C. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health. 1992;82(12):1607–12PubMedCrossRef
15.
go back to reference Landers R, Riccobene A, Beyreuther M, Neusy AJ. Predictors of long-term compliance in attending a worksite hypertension programme. J Hum Hypertens. 1993;7(6):577–9PubMed Landers R, Riccobene A, Beyreuther M, Neusy AJ. Predictors of long-term compliance in attending a worksite hypertension programme. J Hum Hypertens. 1993;7(6):577–9PubMed
16.
go back to reference Ogedegbe G, Mancuso CA, Allegrante JP. Expectations of blood pressure management in hypertensive African-American patients: a qualitative study. J Natl Med Assoc. 2004;96(4):442–9PubMed Ogedegbe G, Mancuso CA, Allegrante JP. Expectations of blood pressure management in hypertensive African-American patients: a qualitative study. J Natl Med Assoc. 2004;96(4):442–9PubMed
17.
go back to reference Mattson RH, Cramer JA, Collins JF. Aspects of compliance: taking drugs and keeping clinic appointments. Epilepsy Res Suppl. 1988;1:111–7PubMed Mattson RH, Cramer JA, Collins JF. Aspects of compliance: taking drugs and keeping clinic appointments. Epilepsy Res Suppl. 1988;1:111–7PubMed
18.
go back to reference McEvoy B, Nydegger R, Williams G. Factors related to patient compliance in the treatment of acne vulgaris. Int J Dermatol. 2003;42(4):274–80PubMedCrossRef McEvoy B, Nydegger R, Williams G. Factors related to patient compliance in the treatment of acne vulgaris. Int J Dermatol. 2003;42(4):274–80PubMedCrossRef
19.
go back to reference Bosworth HB, Dudley T, Olsen MK, et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med. 2006;119(1):70.e9–15 Bosworth HB, Dudley T, Olsen MK, et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med. 2006;119(1):70.e9–15
20.
go back to reference World Health Organization. Adherence to long-term therapies: evidence for action. 2003, [Geneva]: World Health Organization. xv, 198 World Health Organization. Adherence to long-term therapies: evidence for action. 2003, [Geneva]: World Health Organization. xv, 198
Metadata
Title
Appointment-Keeping Behavior is Not Related to Medication Adherence in Hypertensive African Americans
Authors
Gbenga Ogedegbe, MD, MPH, MS
Antoinette Schoenthaler, MA
Senaida Fernandez, PhD
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 8/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0244-y

Other articles of this Issue 8/2007

Journal of General Internal Medicine 8/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.